Beijing Xinbo Technology Trading Co., Ltd.

Many patients with advanced non-small cell lung cancer do not receive chemotherapy. There are many reasons for this, the most common being that the patient is already too weak to bear it.
Research has confirmed that Tarceva can prolong the survival of patients who are not suitable for other lung cancer treatments. Stage machinery has good safety, improves the quality of life, and delays the progression of lung cancer symptoms. Tarceva is an oral treatment, which provides additional benefits by eliminating the cost of intravenous injections and reducing the workload of medical institutions. More importantly, Tarceva treatment avoids the huge expense of dealing with severe toxicities associated with intravenous chemotherapy. Because of this, Tarceva is a more economical treatment.